Search

Your search keyword '"Pirisi, Mario"' showing total 420 results

Search Constraints

Start Over You searched for: Author "Pirisi, Mario" Remove constraint Author: "Pirisi, Mario" Search Limiters Full Text Remove constraint Search Limiters: Full Text
420 results on '"Pirisi, Mario"'

Search Results

2. Gas6/TAM system as potential biomarker for multiple sclerosis prognosis

3. The Role of New Morphological Parameters Provided by the BC 6800 Plus Analyzer in the Early Diagnosis of Sepsis

4. Hepatitis C Virus as a Possible Helper Virus in Human Hepatitis Delta Virus Infection.

5. Gas6/TAM system as potential biomarker for multiple sclerosis prognosis.

6. From MASH to HCC: the role of Gas6/TAM receptors

7. Role of the co-stimulatory molecule inducible T-cell co-stimulator ligand (ICOSL) in the progression of experimental metabolic dysfunction-associated steatohepatitis

8. Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma

11. Unveiling the Mystery of Adult-Onset Still's Disease: A Compelling Case Report.

13. Circadian control of hepatitis B virus replication

14. Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19

16. Role of the co-stimulatory molecule inducible T-cell co-stimulator ligand (ICOSL) in the progression of experimental metabolic dysfunctionassociated steatohepatitis.

17. SARS-CoV-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the RIVALSA prospective cohort

18. Plasma Pattern of Extracellular Vesicles Isolated from Hepatitis C Virus Patients and Their Effects on Human Vascular Endothelial Cells

19. Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter study

20. Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients

21. COVID-19 Biomarkers at the Crossroad between Patient Stratification and Targeted Therapy: The Role of Validated and Proposed Parameters

22. Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors

23. Effect of Lactoferrin on Clinical Outcomes of Hospitalized Patients with COVID-19: The LAC Randomized Clinical Trial

24. Baseline Plasma Osteopontin Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients

26. Identification of the Best Cut-Off Value of PIVKA-II for the Surveillance of Patients at Risk of Hepatocellular Carcinoma Development

27. Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis

33. CGRP Plasma Levels Correlate with the Clinical Evolution and Prognosis of Hospitalized Acute COVID-19 Patients

34. Vitamin D in Systemic Sclerosis: A Review

35. High reproducibility of spleen stiffness measurement by vibration‐controlled transient elastography with a spleen‐dedicated module

37. Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort

38. Anxiety, Stress and Depression in COVID-19 Survivors From an Italian Cohort of Hospitalized Patients: Results From a 1-Year Follow-Up

39. Inflammatory Gene Expression Associates with Hepatitis B Virus cccDNA- but Not Integrant-Derived Transcripts in HBeAg Negative Disease

41. Baseline Plasma Gas6 Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients

42. Liquid biopsy for hepatocellular carcinoma: Preliminary results on the association between postoperative early recurrence and the expression pattern of circulating tumor cells

43. Increased Levels of ICOS and ICOSL Are Associated to Pulmonary Arterial Hypertension in Patients Affected by Connective Tissue Diseases

44. Prognostic Markers in Hospitalized COVID-19 Patients: The Role of IP-10 and C-Reactive Protein

45. Clinical Relevance of Liver Involvement in the Clinical Course of Systemic Sclerosis

46. Oxidative Stress in Non-Alcoholic Fatty Liver Disease

48. Predictors of Mortality and Cardiovascular Outcome at 6 Months after Hospitalization for COVID-19

49. Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register

50. Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher JAK2 Allele Burden in Patients With Myeloproliferative Neoplasms

Catalog

Books, media, physical & digital resources